Agilon Health Stock Set to Reverse Split on Tuesday, March 31st (NYSE:AGL)

Agilon Health, Inc. (NYSE:AGL) shares are scheduled to reverse split on the morning of Tuesday, March 31st. The 1-25 reverse split was announced on Wednesday, March 18th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, March 30th.

Agilon Health Stock Down 11.0%

Shares of Agilon Health stock opened at $0.38 on Friday. Agilon Health has a 1 year low of $0.34 and a 1 year high of $6.08. The firm has a market cap of $157.65 million, a price-to-earnings ratio of -0.40 and a beta of 0.11. The company has a 50-day moving average of $0.62 and a 200 day moving average of $0.77. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). Agilon Health had a negative net margin of 6.60% and a negative return on equity of 120.82%. The business had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.46 billion. As a group, sell-side analysts anticipate that Agilon Health will post -0.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AGL has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, January 21st. BTIG Research reissued a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Wells Fargo & Company lifted their price objective on Agilon Health from $1.00 to $1.50 and gave the stock an “overweight” rating in a report on Friday, February 27th. Royal Bank Of Canada upgraded Agilon Health from a “hold” rating to a “moderate buy” rating in a research report on Wednesday, December 3rd. Finally, Barclays lowered their target price on Agilon Health from $1.00 to $0.50 and set an “underweight” rating on the stock in a report on Friday, February 27th. Three equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Agilon Health presently has an average rating of “Hold” and an average target price of $2.18.

Institutional Trading of Agilon Health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. CenterBook Partners LP increased its holdings in shares of Agilon Health by 492.4% in the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Agilon Health by 2.6% during the second quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company’s stock worth $16,462,000 after purchasing an additional 178,477 shares during the last quarter. SG Americas Securities LLC boosted its holdings in shares of Agilon Health by 60.1% in the second quarter. SG Americas Securities LLC now owns 230,912 shares of the company’s stock valued at $531,000 after purchasing an additional 86,723 shares during the period. XTX Topco Ltd lifted its stake in Agilon Health by 583.2% in the second quarter. XTX Topco Ltd now owns 400,760 shares of the company’s stock worth $922,000 after acquiring an additional 342,100 shares during the period. Finally, Norges Bank bought a new stake in Agilon Health during the 2nd quarter valued at $3,299,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.